Emotional State and Compliance with a Medical Regimen of the Patients with Systemic Lupus Erythematosus / 성인간호학회지

ABSTRACT

This descriptive study was conducted between October 1, and December 31, 1998 in order to provide basic data for understanding the emotional states of patients with systemic lupus erythematosus and their compliance with a medical regimen. Data was collected by using questionnaires administered to 100 lupus inpatients and outpatients at the Kangnam St. Mary's Hospital. Frequencies, percentage, average, standard deviation, t-test, ANOVA, Duncan's multiple range test, Pearson correlation coefficients, and stepwise multiple regression were applied to the data using the SAS program. The results of study are summarized below. The mean compliance score was 91.21. The highest compliance score was found in "risk factor management", followed by "taking medicine", "follow-up care", "daily life management", "stress management", "diet", "activity and rest" in that sequence. The mean depression score was 43.58. 24% for subjects who showed more than mild depression. The compliance score of depressed subjects was significantly lower than that of the subjects without depression. The mean score of anxiety was 44.01. 36% for subjects who had scores lower than 40 points, 37% for those between 41-50 points, and 27% for those with more than 51 points. As for compliance scores according to anxiety levels, the compliance scores for those with anxiety scores of below 40 significantly higher than that of those of the above 51 group. There was a negative correlation between compliance and depression and between compliance and anxiety. In addition, a strong positive relationship was found between depression and anxiety. The major variable affecting compliance was anxiety, accounting for 13.6%. We concluded that when we care for the patients with lupus, we have to consider the outcomes of this study because emotional status affects the lupus patients' compliance. In addition, it is necessary to develop nursing interventions in order to alleviate the lupus patient's depression and anxiety.